222 related articles for article (PubMed ID: 22676424)
1. Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine.
Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Kurkinen KJ; Neuvonen PJ; Olkkola KT
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):325-32. PubMed ID: 22676424
[TBL] [Abstract][Full Text] [Related]
2. St John's wort greatly decreases the plasma concentrations of oral S-ketamine.
Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Neuvonen PJ; Olkkola KT
Fundam Clin Pharmacol; 2012 Dec; 26(6):743-50. PubMed ID: 21635359
[TBL] [Abstract][Full Text] [Related]
3. Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administration.
Noppers I; Olofsen E; Niesters M; Aarts L; Mooren R; Dahan A; Kharasch E; Sarton E
Anesthesiology; 2011 Jun; 114(6):1435-45. PubMed ID: 21508826
[TBL] [Abstract][Full Text] [Related]
4. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
Villikka K; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine.
Hagelberg NM; Peltoniemi MA; Saari TI; Kurkinen KJ; Laine K; Neuvonen PJ; Olkkola KT
Eur J Pain; 2010 Jul; 14(6):625-9. PubMed ID: 19897389
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin markedly decreases the exposure to oral and intravenous tramadol.
Saarikoski T; Saari TI; Hagelberg NM; Neuvonen M; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
Eur J Clin Pharmacol; 2013 Jun; 69(6):1293-301. PubMed ID: 23242004
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.
Fanta S; Kinnunen M; Backman JT; Kalso E
Eur J Clin Pharmacol; 2015 Apr; 71(4):441-7. PubMed ID: 25724645
[TBL] [Abstract][Full Text] [Related]
8. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
Backman JT; Granfors MT; Neuvonen PJ
Eur J Clin Pharmacol; 2006 Jun; 62(6):451-61. PubMed ID: 16758262
[TBL] [Abstract][Full Text] [Related]
10. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
[TBL] [Abstract][Full Text] [Related]
11. Exposure to oral S-ketamine is unaffected by itraconazole but greatly increased by ticlopidine.
Peltoniemi MA; Saari TI; Hagelberg NM; Reponen P; Turpeinen M; Laine K; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2011 Aug; 90(2):296-302. PubMed ID: 21716267
[TBL] [Abstract][Full Text] [Related]
12. Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.
Kyrklund C; Backman JT; Neuvonen M; Neuvonen PJ
Br J Clin Pharmacol; 2004 Feb; 57(2):181-7. PubMed ID: 14748817
[TBL] [Abstract][Full Text] [Related]
13. Effect of rifampicin on the pharmacokinetics of pioglitazone.
Jaakkola T; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ
Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin.
Kivistö KT; Villikka K; Nyman L; Anttila M; Neuvonen PJ
Clin Pharmacol Ther; 1998 Dec; 64(6):648-54. PubMed ID: 9871429
[TBL] [Abstract][Full Text] [Related]
15. S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children.
Weber F; Wulf H; Gruber M; Biallas R
Paediatr Anaesth; 2004 Dec; 14(12):983-8. PubMed ID: 15601346
[TBL] [Abstract][Full Text] [Related]
16. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ketamine and norketamine enantiomers after racemic or S-ketamine IV bolus administration in dogs during sevoflurane anaesthesia.
Romagnoli N; Bektas RN; Kutter AP; Barbarossa A; Roncada P; Hartnack S; Bettschart-Wolfensberger R
Res Vet Sci; 2017 Jun; 112():208-213. PubMed ID: 28521255
[TBL] [Abstract][Full Text] [Related]
18. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.
Peltoniemi MA; Hagelberg NM; Olkkola KT; Saari TI
Clin Pharmacokinet; 2016 Sep; 55(9):1059-77. PubMed ID: 27028535
[TBL] [Abstract][Full Text] [Related]
19. Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects.
Ebert U; Thong NQ; Oertel R; Kirch W
Eur J Clin Pharmacol; 2000 Jul; 56(4):299-304. PubMed ID: 10954343
[TBL] [Abstract][Full Text] [Related]
20. Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats.
Moaddel R; Sanghvi M; Ramamoorthy A; Jozwiak K; Singh N; Green C; O'Loughlin K; Torjman M; Wainer IW
J Pharm Biomed Anal; 2016 Aug; 127():3-8. PubMed ID: 27017097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
